Clinical Trial Update: A Study to Evaluate Safety of ASC40 Tablets in Patients With Moderate to Severe Acne Vulgaris [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the safety of ASC40 tablets in patients with moderate to severe acne vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• ASC40

Snippet

Sponsor: Ascletis Pharmaceuticals Co., Ltd. | Conditions: Acne | Phase 3 | Status: COMPLETED